Tara Bancroft
Stock Analyst at TD Cowen
(2.71)
# 1,844
Out of 4,983 analysts
9
Total ratings
57.14%
Success rate
22.68%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tara Bancroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LNTH Lantheus Holdings | Maintains: Buy | $95 → $80 | $50.81 | +57.45% | 1 | Sep 15, 2025 | |
| TGTX TG Therapeutics | Initiates: Buy | $50 | $32.04 | +56.05% | 1 | Oct 29, 2024 | |
| PTGX Protagonist Therapeutics | Initiates: Buy | $65 | $59.17 | +9.85% | 1 | Sep 24, 2024 | |
| OCUL Ocular Therapeutix | Upgrades: Buy | $7 → $11 | $12.15 | -9.43% | 3 | Jun 20, 2024 | |
| GERN Geron | Initiates: Buy | $10 | $1.27 | +687.40% | 1 | Apr 29, 2024 | |
| MRUS Merus | Initiates: Outperform | n/a | $68.06 | - | 1 | Aug 21, 2023 | |
| BCYC Bicycle Therapeutics | Initiates: Outperform | n/a | $6.91 | - | 1 | Aug 31, 2022 |
Lantheus Holdings
Sep 15, 2025
Maintains: Buy
Price Target: $95 → $80
Current: $50.81
Upside: +57.45%
TG Therapeutics
Oct 29, 2024
Initiates: Buy
Price Target: $50
Current: $32.04
Upside: +56.05%
Protagonist Therapeutics
Sep 24, 2024
Initiates: Buy
Price Target: $65
Current: $59.17
Upside: +9.85%
Ocular Therapeutix
Jun 20, 2024
Upgrades: Buy
Price Target: $7 → $11
Current: $12.15
Upside: -9.43%
Geron
Apr 29, 2024
Initiates: Buy
Price Target: $10
Current: $1.27
Upside: +687.40%
Merus
Aug 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $68.06
Upside: -
Bicycle Therapeutics
Aug 31, 2022
Initiates: Outperform
Price Target: n/a
Current: $6.91
Upside: -